Clinical Trial Update: Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD

View source ↗

Summary

A completed Northwestern University study investigates unique pathogenic macrophages involved in systemic sclerosis-associated interstitial lung disease (system…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Systemic Sclerosis
• Systemic Sclerosis-associated Interstitial Lung Disease

Snippet

Sponsor: Northwestern University | Conditions: Fibrosis Lung, Systemic Sclerosis | Status: COMPLETED